Govt approves prices for 52 advanced life-saving drugs
The Pakistan government has approved prices for 52 new essential medicines including those used to treat diseases including cancer, hypertension, diabetes, and respiratory conditions, as well as vaccines for infections. The move will likely improve access of patients to the advanced drugs. “A Cabinet Committee constituted by the Prime Minister for drug pricing that was recently chaired by Federal…
The Pakistani government has recently approved prices for 52 advanced life-saving drugs, including treatments for cancer, hypertension, diabetes, and respiratory conditions, as well as vaccines for infections. This development, which follows an earlier approval of 35 medicines in April 2026, aims to improve access to these essential medicines for patients.
The Cabinet Committee on Drug Pricing, chaired by Federal Minister for Finance and Revenue Muhammad Aurangzeb, set the pricing for these 52 new medicines. Once the formal implementation of the regulated pricing is completed, which could take one to two months, pharmaceutical companies will be able to begin manufacturing and importing these drugs.
The move is expected to benefit patients, as they will have access to advanced treatments that were previously inaccessible due to delays in price fixation, forcing them to either go without treatment or rely on costly and unregulated smuggled medicines.
Brief written by urgent.news from Business Recorder's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
